CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
- 28 April 2020
- journal article
- review article
- Published by Wiley in IUBMB Life
- Vol. 72 (8), 1603-1621
- https://doi.org/10.1002/iub.2296
Abstract
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR‐associated protein9) may be viewed as an adaptive bacterial immune system. When a virus infects a bacterium, a fragment of the virus genome is inserted into the CRISPR sequence of the bacterial genome as a memory. When the bacterium becomes infected again with the same virus, an RNA molecule that is a transcript of the memory sequence, directs Cas9, an endonuclease, to the complementary region of the virus genome, and Cas9 disables the virus by a double‐strand break. In recent years, studies have shown that by designing synthetic RNA molecules and delivering them along with Cas9 into eukaryotic cells, different regions of the cell's genome can be targeted and manipulated. These findings have drawn much attention to this new technology and it has been shown that CRISPR/Cas9 gene editing can be used to treat some human diseases. These include infectious diseases and autoimmune diseases. In this review article, in addition to a brief overview of the biology of the CRISPR/Cas9 system, we collected the most recent findings on the applications of CRISPR/Cas9 technology for better investigation of the pathogenesis and treatment of viral infections (human immunodeficiency virus infection, hepatitis virus infections, and onco‐virus infections), non‐viral infections (parasitic, fungal, and bacterial infections), and autoimmune diseases.Keywords
This publication has 143 references indexed in Scilit:
- Epstein-Barr Viral BNLF2a Protein Hijacks the Tail-anchored Protein Insertion Machinery to Block Antigen Processing by the Transport Complex TAPOnline Journal of Public Health Informatics, 2011
- Interplay between HIV-1 infection and host microRNAsNucleic Acids Research, 2011
- CRISPR-based adaptive immune systemsCurrent Opinion in Microbiology, 2011
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus InfectionsClinical Microbiology Reviews, 2011
- CCL8/MCP‐2 is a target for mir‐146a in HIV‐1‐infected human microglial cellsThe FASEB Journal, 2010
- Inflammatory Bowel DiseaseThe New England Journal of Medicine, 2009
- Epstein-Barr Virus-Induced miR-155 Attenuates NF-κB Signaling and Stabilizes Latent Virus PersistenceJournal of Virology, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- HBV pathogenesis in animal models: Recent advances on the role of plateletsJournal of Hepatology, 2007